Compounding pharmacy and IBD 50 newcomer Hims & Hers Health (HIMS) reported bullish earnings and sales growth late Monday. But Hims stock tanked.
Hims stock has gained notoriety over the last ye… [+2543 chars]
IBD 50's No. 2, Hims & Hers, Crashes 15% Despite Upbeat Earnings - Investor's Business Daily
Hims & Hers Health reported bullish earnings and sales growth late Monday.
By:ALLISON GATLIN, Investor's Business Daily
Source:Investor's Business Daily
Published:
Related News
Asian Stocks to Gain as Trump Touts Greenland Deal: Markets Wrap - Bloomberg.com
European stocks rebounded after US President Donald Trump abandoned his tariff threats against Europe, easing concerns over a renewed trade war.
Bloomberg•Anand Krishnamoorthy, Andre Janse Van Vuuren
Dow Jones Futures Rise After Trump Greenland Shift Fuels Stocks; Google, Eli Lilly Lead 8 New Buys - Investor's Business Daily
President cites "framework" for a future deal that will involve mineral rights.
Investor's Business Daily
Bezos' Blue Origin announces satellite rival to Musk's Starlink - BBC
Blue Origin will be focused on businesses and governments, while Starlink also offers services to individual customers.
BBC News